Subscribe to Newsletter

Retina

Business & Profession Basic & Translational Research

Image of the Month

An artistic simulation of sight with AMD.
Subspecialties Retina

No Synergy

| Ruth Steer

Is pegpleranib + ranibizumab better than ranibizumab alone? Phase III results suggest not…
Subspecialties Retina

Same Difference

| Ruth Steer

Real-world observational study comparing ranibizumab and aflibercept shows similar outcomes.
Subspecialties Business and Innovation

Hindsight for Foresight

| Mark Hillen

Looking back at 2016's predictions of the future.
Subspecialties Retina

Consider the Alternative

| Anat Loewenstein

When it comes to treating retinal disease, VEGF isn’t the only game in town.
Subspecialties Retina

OCT Angiography Module for SPECTRALIS® now available

Heidelberg Engineering has started delivering the OCT-Angiography Module to SPECTRALIS® customers outside the United States. The OCT Angiography Module non-invasively produces detailed three-dimensional representations of the perfused retinal and choroidal vasculatures.
Subspecialties Retina

Diabetic Macular Edema (DME): See the Person Behind the Eye

DME treatment and the impact it has on the macula – and the patient.
Subspecialties Cataract

Edema Enigma

| Ruth Steer

Have reports of NSAIDS preventing post-cataract macular edema been exaggerated?
Subspecialties Retina

Through Thick and Thin

| Roisin McGuigan

A thinner retina could predict neurodegeneration in diabetes - and vice versa.
Subspecialties Basic & Translational Research

Sugar Rush

| Roisin McGuigan

Could glucose metabolism be an alternative target for treating RP?
Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

December Issue of The Ophthalmologist
Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: